Trial Profile
Study of NTBC for Tyrosinemia I
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Nitisinone (Primary)
- Indications Tyrosinaemia type I
- Focus Adverse reactions; Therapeutic Use
- 27 Mar 2015 New trial record